Core Laboratories Reports Mixed 2025 Results with Profit Decline, Significant Share Repurchases, and Resolves Prior Accounting Error
CLB sits 63% above its 52-week low of $9.72 on elevated volume (1.9× avg).
Summary
Core Laboratories Inc. filed its 2025 annual report, showing a decline in net income and cash flow, but also a substantial $15.5 million in share repurchases and a reduction in long-term debt. The company also finalized corrections to previously reported income tax expense and confirmed NYSE compliance.
Key Events · Earnings and Guidance · CLB
-
Financial Performance Decline
Net income attributable to Core Laboratories Inc. decreased by 5.5% to $29.669 million, and diluted EPS fell by 4.5% to $0.63 in 2025 compared to 2024. Cash flow from operations also saw a significant drop of $19.4 million.
-
Significant Share Repurchases
The company repurchased 1,194,685 shares of common stock for $15.5 million in 2025, representing a notable capital return to shareholders.
-
Debt Reduction and Healthy Ratios
Long-term debt, net, decreased by $15.856 million to $110.255 million. The company maintains healthy leverage (1.10:1 Debt to Adjusted EBITDA) and interest coverage (7.79:1) ratios.
-
Resolution of Accounting & Compliance Issues
The filing includes a further correction to the income tax expense for 2025, adjusting the prior 8-K/A, and confirms the company has regained compliance with NYSE listing standards after a delayed filing.
Analysis · CLB · Energy & Transportation
Core Laboratories' 2025 annual report presents a mixed financial picture, with a notable decline in net income, diluted EPS, and cash flow from operations. This indicates operational challenges or a tougher market environment. However, the company demonstrated strong capital management by reducing its long-term debt and executing a significant share repurchase program, which could be viewed positively by investors. The resolution of the previously disclosed income tax reporting error and the confirmation of NYSE compliance are also positive for corporate governance and transparency. Investors should monitor the impact of geopolitical conflicts, particularly in the Middle East, as these are explicitly identified as significant risks that could affect future performance and demand for the company's services.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CLB was trading at $15.89 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $754.8M. The 52-week trading range was $9.72 to $20.36. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.